A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients
Open Access
- 22 November 2021
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 219 (1)
- https://doi.org/10.1084/jem.20202084
Abstract
Immune checkpoint inhibitor (ICI) therapy continues to revolutionize melanoma treatment, but only a subset of patients respond. Major efforts are underway to develop minimally invasive predictive assays of ICI response. Using single-cell transcriptomics, we discovered a unique CD8 T cell blood/tumor-shared subpopulation in melanoma patients with high levels of oxidative phosphorylation (OXPHOS), the ectonucleotidases CD38 and CD39, and both exhaustion and cytotoxicity markers. We called this population with high levels of OXPHOS “CD8+ TOXPHOS cells.” We validated that higher levels of OXPHOS in tumor- and peripheral blood–derived CD8+ TOXPHOS cells correlated with ICI resistance in melanoma patients. We then developed an ICI therapy response predictive model using a transcriptomic profile of CD8+ TOXPHOS cells. This model is capable of discerning responders from nonresponders using either tumor or peripheral blood CD8 T cells with high accuracy in multiple validation cohorts. In sum, CD8+ TOXPHOS cells represent a critical immune population to assess ICI response with the potential to be a new target to improve outcomes in melanoma patients.Keywords
Funding Information
- Cleveland Clinic
This publication has 94 references indexed in Scilit:
- Reconsidering the Paradigm of Cancer Immunotherapy by Computationally Aided Real-time PersonalizationCancer Research, 2012
- Type I-IFNs control GVHD and GVL responses after transplantationBlood, 2011
- Interleukin-7 Inhibits Tumor-Induced CD27−CD28− Suppressor T Cells: Implications for Cancer ImmunotherapyClinical Cancer Research, 2011
- Comeback kids: CD8+ suppressor T cells are back in the gameJCI Insight, 2010
- Circos: An information aesthetic for comparative genomicsGenome Research, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- The Actin Cytoskeleton in T Cell ActivationAnnual Review of Immunology, 2008
- IFN‐γ is an Absolute Requirement for Spontaneous Acceptance of Liver AllograftsAmerican Journal of Transplantation, 2003
- Role of IFN-g in Allograft RejectionCritical Reviews™ in Immunology, 2002
- Measurement of Mitochondrial Membrane Potential Using Fluorescent Rhodamine DerivativesBiophysical Journal, 1999